πŸ‡ΊπŸ‡Έ FDA
Patent

US 11096956

Antisense oligomers and uses thereof

granted A61KA61K31/7125A61K38/005

Quick answer

US patent 11096956 (Antisense oligomers and uses thereof) held by STOKE THERAPEUTICS, INC. expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
STOKE THERAPEUTICS, INC.
Grant date
Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/7125, A61K38/005, A61K38/179, A61K47/6807